Kamil Piska

8PUBLICATIONS
23CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of diseaseBiologically active moleculesMedical infection agents (incl. prions)Cheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 10, 2025
Casticin inhibits AKR1C3 and enhances abiraterone efficacy in castration-resistant prostate cancer.

Kamil Piska, Michał Zubek, Adam Bucki

|Jul 12, 2025
New Quipazine Derivatives Active Against Drug-Resistant Oncogenic Helicobacter pylori Strains with Biofilm.

Katarzyna Grychowska, Karolina Klesiewicz, Joanna Pęgiel

|Jul 04, 2024
Aclarubicin: contemporary insights into its mechanism of action, toxicity, pharmacokinetics, and clinical standing.

Aleksandra Murzyn, Justyna Orzeł, Natalia Obajtek

|Mar 20, 2024
Improving Activity of New Arylurea Agents against Multidrug-Resistant and Biofilm-Producing Staphylococcus epidermidis.

Vittorio Canale, Iwona Skiba-Kurek, Karolina Klesiewicz

|May 27, 2023
Saponin Fraction CIL1 from Lysimachia ciliata L. Enhances the Effect of a Targeted Toxin on Cancer Cells.

Paulina Koczurkiewicz-Adamczyk, Karolina Grabowska, Elżbieta Karnas

Pageof 2